Kathleen E. Hughes

Prevea Health

Papers

1

Total Citations

127

H-Index

1

About

Dr. Kathleen E. Hughes is a leading health economist whose research centers on the cost-effectiveness of cancer treatments, with a particular focus on prostate cancer. Her work provides critical data to guide clinical decision-making and health policy. Her most impactful contribution is a landmark 2012 study, "Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost‐utility analysis," which has amassed 127 citations. This paper stands as the most comprehensive cost-effectiveness analysis of its kind, directly comparing multiple treatment alternatives for localised prostate cancer—a field where high-quality comparative studies were previously scarce. By modeling lifetime costs and patient outcomes, Dr. Hughes’s work offers a rigorous framework for evaluating the trade-offs between different primary treatments, helping patients and clinicians navigate a complex decision landscape. Her research is essential for anyone interested in the intersection of oncology, health economics, and value-based care, demonstrating how rigorous modeling can illuminate the true costs and benefits of medical interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
127
Total Citations
127
Avg Citations/Paper
🏆 Most Cited Paper
Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost‐utility analysis
127 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Prevea Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago